Entera Bio logo

Entera Bio Share Price (NASDAQ: ENTX)

$1.95

Last updated on

Check the interactive Entera Bio Stock chart to analyse performance

Entera Bio stock performance

as on August 23, 2025 at 1:25 AM IST

  • Today's Low:$1.93
    Today's High:$1.99

    Day's Volatility :3.02%

  • 52 Weeks Low:$1.50
    52 Weeks High:$2.79

    52 Weeks Volatility :46.22%

Entera Bio Stock Returns

PeriodEntera Bio LtdIndex (Russel 2000)
3 Months
3.76%
0.0%
6 Months
-6.76%
0.0%
1 Year
16.27%
0.0%
3 Years
37.86%
-8.6%

Entera Bio Ltd Key Stats

Check Entera Bio key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.95
Open
$1.99
Today's High
$1.99
Today's Low
$1.93
Market Capitalization
$89.0M
Today's Volume
$35.2K
52 Week High
$2.79
52 Week Low
$1.5006
Revenue TTM
$166.0K
EBITDA
$-10.6M
Earnings Per Share (EPS)
$-0.26
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-82.22%

Stock Returns calculator for Entera Bio Stock including INR - Dollar returns

The Entera Bio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Entera Bio investment value today

Current value as on today

₹1,21,786

Returns

₹21,786

(+21.79%)

Returns from Entera Bio Stock

₹17,470 (+17.47%)

Dollar Returns*

₹4,316 (+4.32%)

Indian investors sentiment towards Entera Bio Stock

77%

Period: Jul 25, 2025 to Aug 24, 2025. Change in 30 Days versus previous period

Search interest for Entera Bio Stock from India on INDmoney has increased by 77% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Entera Bio Ltd

  • Name

    Holdings %

  • Knoll Capital Management LP

    12.94%

  • Point72 Asset Management, L.P.

    5.93%

  • Schonfeld Strategic Advisors LLC

    1.32%

  • Parkman Healthcare Partners LLC

    0.78%

  • Northern Trust Corp

    0.44%

  • Renaissance Technologies Corp

    0.14%

Analyst Recommendation on Entera Bio Stock

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Entera Bio(by analysts ranked 0 to 5 stars)

Entera Bio Share Price Target

What analysts predicted

Upside of 412.82%

Target:

$10.00

Current:

$1.95

Entera Bio share price target is $10.00, a slight Upside of 412.82% compared to current price of $1.95 as per analysts' prediction.

Entera Bio Stock Insights

  • Price Movement

    In the last 7 days, ENTX stock has moved down by -3.5%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 82.0K → 42.0K (in $), with an average decrease of 48.8% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 2.56M → -2.65M (in $), with an average decrease of 203.5% per quarter
  • ENTX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.6% return, outperforming this stock by 53.7%
  • ENTX vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 105.6% return, outperforming this stock by 67.7%
  • Price to Sales

    ForENTX every $1 of sales, investors are willing to pay $482.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.9 for every $1 of sales.

Entera Bio Technicals Summary

Sell

Neutral

Buy

Entera Bio is currently in a neutral trading position according to technical analysis indicators.

Entera Bio Ltd Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Entera Bio Ltd logo
3.76%
-6.76%
16.27%
37.86%
47.33%
Regeneron Pharmaceuticals, Inc. logo
4.66%
-17.37%
-50.86%
-2.39%
-3.46%
Beone Medicines Ltd logo
7.62%
21.35%
57.45%
78.28%
25.05%
Vertex Pharmaceuticals Incorporated logo
-15.87%
-17.97%
-18.14%
35.67%
45.07%
Alnylam Pharmaceuticals, Inc. logo
38.16%
82.49%
68.79%
112.36%
238.79%

About Entera Bio Ltd

Entera Bio Ltd., a clinical stage company, focuses on developing oral peptide or protein replacement therapies for unmet medical needs. The company leverages its N-Tab platform that is designed to simultaneously stabilize the peptide in the gastrointestinal tract and promote its absorption into the bloodstream. It also develops EB613, an oral PTH (1-34), that has completed Phase 2 clinical trial for the treatment of post-menopausal women with low bone mineral density and high-risk osteoporosis; and has completed Phase 1 clinical trial to treat stress fractures. In addition, the company is developing EB612, a tablet peptide replacement therapy for hypoparathyroidism. Further, it develops oral oxyntomodulin (OXM), a dual targeted GLP1/glucagon peptide, in tablet form for the treatment of obesity and metabolic disorders; and GLP-2 peptide tablet as an injection-free alternative for patients suffering from rare malabsorption conditions, such as short bowel syndrome. The company has research collaboration agreement with OPKO Biologics, Inc. Entera Bio Ltd. was incorporated in 2009 and is headquartered in Jerusalem, Israel.
Organization
Entera Bio
Employees
19
CEO
Ms. Miranda J. Toledano M.B.A.
Industry
Health Technology

Key Management of Entera Bio Ltd

NameTitle
Ms. Miranda J. Toledano M.B.A.
CEO & Director
Ms. Dana Yaacov-Garbeli CPA
Chief Financial Officer
Dr. Hillel Galitzer M.B.A., Ph.D.
Chief Operating Officer
Dr. Gregory Burshtein Ph.D.
Chief of Research & Development
Dr. Rachel B. Wagman
Chief Clinical Advisor
Ms. Leslie Gautam
Chief Business Officer

Important FAQs about investing in ENTX Stock from India :

What is Entera Bio share price today?

Entera Bio share price today is $1.95 as on at the close of the market. Entera Bio share today touched a day high of $1.99 and a low of $1.93.

What is the 52 week high and 52 week low for Entera Bio share?

Entera Bio share touched a 52 week high of $2.79 and a 52 week low of $1.50. Entera Bio stock price today i.e. is closed at $1.95, lower by 30.11% versus the 52 week high.

How to invest in Entera Bio Stock (ENTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Entera Bio on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Entera Bio Shares that will get you 0.7692 shares as per Entera Bio share price of $1.95 per share as on August 23, 2025 at 1:25 AM IST.

What is the minimum amount required to buy Entera Bio Stock (ENTX) from India?

Indian investors can start investing in Entera Bio (ENTX) shares with as little as ₹87.521 or $1 (as of August 25, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.21 in Entera Bio stock (as per the Rupee-Dollar exchange rate as on August 25, 2025). Based on Entera Bio share’s latest price of $1.95 as on August 23, 2025 at 1:25 AM IST, you will get 5.1282 shares of Entera Bio. Learn more about fractional shares .

What are the returns that Entera Bio has given to Indian investors in the last 5 years?

Entera Bio stock has given 47.33% share price returns and 18.0% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?